2026-01-24 - Analysis Report
**Philip Morris International Inc. Stock Analysis**

**Company Overview**: Philip Morris International Inc. is a multinational tobacco company with a wide range of cigarette and tobacco products.

**Return Rate Comparison**

* Cumulative return of review stock (PM): 136.12%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence: 9.70 (Relative divergence: 63.30%)
* This suggests that Philip Morris International Inc. stock has significantly outperformed the S&P 500 index over the review period.

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -28.0% | 22.9% | -40.0% | 0.5 | 103.9B |
| 2017-2019 | -1.0% | 22.9% | -26.0% | 0.5 | 132.4B |
| 2018-2020 | -3.0% | 31.1% | -27.0% | 0.8 | 128.9B |
| 2019-2021 | 40.0% | 31.1% | -26.0% | 0.8 | 147.9B |
| 2020-2022 | 37.0% | 31.1% | 30.0% | 0.7 | 157.6B |
| 2021-2023 | 26.0% | 19.8% | 6.0% | 0.5 | 146.4B |
| 2022-2024 | 32.0% | 19.8% | 2.0% | 0.4 | 187.3B |
| 2023-2025 | 79.0% | 19.5% | 4.0% | 0.2 | 249.7B |

* The company has experienced varying degrees of success over the years, with some periods showing significant growth and others experiencing losses.
* Beta values are relatively high across all periods, indicating higher volatility.
* Alpha values are mixed, with some periods showing positive results and others showing negative results.

**Recent Stock Price Fluctuations**

* Close: $173.02
* 5-day SMA: $170.54
* 20-day SMA: $164.36
* 60-day SMA: $156.94
* The stock has experienced a moderate rebound over the last 5 days, with a relative increase of 1.75%. However, the 20-day and 60-day SMAs are still below the current price, indicating a potential short-term correction.

**RSI, PPO Index Indicators**

* Market Risk Indicator (MRI): 0.70 (Medium investment)
* RSI: 67.72
* PPO: 0.40
* Hybrid Signal: Buy (Cash 0%)
* Recent relative divergence change: 1.40 (+) improving
* 7-day Rank change: 60 (+) rank up
* 7-day Dynamic Expected Return change: -9.10 (-) worsening
* The RSI and PPO indices are neutral, with a slight lean towards the buy side.
* The expected return is -15.60%, indicating a potential worsening in performance.

**Recent News & Significant Events**

* Earnings Preview: What to Expect From Philip Morrisâ€™ Report - Yahoo Finance (news.google.com)
* Teacher Retirement System of Texas Has $91.74 Million Stock Holdings in Philip Morris International Inc. $PM - MarketBeat (news.google.com)
* Philip Morris Seeks MRTP Status for ZYN, Reports 14% Sales Surge - Intellectia AI (news.google.com)
* Jefferies downgrades Philip Morris stock rating to Hold on limited growth - Investing.com (news.google.com)
* Philip Morris: Strong 4% Yield, But Nicotine Product Bans Are A Threat To Rapid Growth - Seeking Alpha (news.google.com)
* These recent news headlines indicate a mix of positive and negative sentiment, with some analysts expressing concerns about the company's future prospects.

**Analyst Opinions**

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 1.83 (~Buy)
	+ Opinions: 16
	+ Target Price (avg/high/low): 180.38 / 200.00 / 158.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-24 | 2.23 | 10.85 B$ |
| 2025-07-25 | 1.95 | 10.14 B$ |
| 2025-04-24 | 1.72 | 9.30 B$ |
| 2024-10-24 | 1.98 | 9.91 B$ |
| 2025-10-24 | 1.98 | 9.91 B$ |

* The company has consistently reported higher revenue figures in recent quarters, with EPS also showing an upward trend.
* However, the profitability indicators, such as profit margin and ROE, are mixed and have declined in some quarters.

**Financial Information**

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.85B | 67.85% |
| 2025-06-30 | $10.14B | 67.66% |
| 2025-03-31 | $9.30B | 67.32% |
| 2024-12-31 | $9.71B | 64.73% |
| 2024-09-30 | $9.91B | 66.04% |

* The revenue has shown a steady increase in recent quarters, with profit margins also remaining relatively stable.
* However, the profitability indicators, such as ROE, are mixed and have declined in some quarters.

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $-10.91B | -31.87% |
| 2025-06-30 | $-11.97B | -25.40% |
| 2025-03-31 | $-10.90B | -24.68% |
| 2024-12-31 | $-11.75B | 4.93% |
| 2024-09-30 | $-9.69B | -31.79% |

* The equity has shown a significant decline in recent quarters, with ROE also indicating a mixed trend.

**Comprehensive Analysis (Summary of previous items)**

* The company has reported varying degrees of success over the years, with some periods showing significant growth and others experiencing losses.
* The recent stock price fluctuations indicate a moderate rebound, but the SMAs are still below the current price.
* The RSI and PPO indices are neutral, with a slight lean towards the buy side.
* The expected return is -15.60%, indicating a potential worsening in performance.
* The recent news and significant events indicate a mix of positive and negative sentiment.
* The analyst opinions suggest a moderate buy rating, with a target price range of $180.38 to $200.00.
* The recent earnings analysis indicates a steady increase in revenue and EPS, but mixed trends in profitability.
* The financial information suggests a steady increase in revenue, but mixed trends in profitability indicators.
* Overall, the company's performance is mixed, with both positive and negative trends evident in the data.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.